Pure Global AI
NCT06316011Not yet recruiting

MCG for Risk Stratifications of Patients With Chest Pain

Magnetocardiography in the Identification and Risk Stratification of Patients With Acute Chest Pian
Qilu Hospital of Shandong UniversityClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Acute Coronary Syndrome
Drug/Device/Intervention
Magnetocardiography
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Qilu Hospital of Shandong University
Timeline & enrollment
Phase
N/A
Start date
Mar 20, 2024
End date
Aug 31, 2024
Enrollment
3620 participants
Primary outcome

Efficacy of MCG for the detection and risk stratification in patients with chest pain

Summary

This prospective cohort study is aimed at identification and risk stratification of patients
 who have symptoms of acute chest pain suspected with acute coronary syndrome （ACS） using
 Magnetocardiography （MCG）.

ICD-10 classifications
Acute myocardial infarctionAcute myocardial infarction, unspecifiedAcute subendocardial myocardial infarctionAcute ischaemic heart disease, unspecifiedOther acute ischaemic heart diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06316011
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06316011 through Pure Global AI's free database. This phase not specified trial is sponsored by Qilu Hospital of Shandong University and is currently Not yet recruiting. The study focuses on Acute Coronary Syndrome. Target enrollment is 3620 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.